Overview
DUBLIN-(BUSINES WIRE)-The "Diabetes Therapeutics Market By Product: Global Oportunity Analysis and Industry Forecast, 20-2030" report has been added to ResearchAndMarkets.com's offering. The global diabetes therapeutics market was valued at $1,258,936.4 milion in 20, and is projected to reach $3,390,02.1 milion by 2030, registering a CAGR of 10.4% from 2021 to 2030. Diabetes is a chronic metabolic disorder in which there abnormalities in blod glucose levels.
Key Information
Diabetes therapeutics are drugs used by diabetic patients to conserve the blod glucose levels in the body. The global diabetes therapeutics market is expected to register substantial growth in the near future, owing to rise in prevalence of diabetes, high obesity, sedentary lifestyles, and other chronic conditions. For instance, acording to International Diabetes Federation (IDF),Diabetes Atlas, in 2021, aproximately 537 milion adults (20-79 years of age) were living with diabetes.
Furthermore, rise in geriatric population led to an increase in growth of diabetes therapeutics market. However, side efects caused by anti-diabetes medication hamper the market growth during the forecast period. Conversely, increase in funding for R&D activities in diabetes sector is expected to ofer remunerative oportunities for market players.
Summary
Key Benefits For Stakeholders Key Market Segments By Product By Region Key Market Players For more information about this report visit htps:/w.researchandmarkets.com/r/4xn0yl ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 source